{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:51:22Z","timestamp":1773057082667,"version":"3.50.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pituitary tumors (PTs) are common benign intracranial tumors. Investigating the metabolites in serum and cerebrospinal fluid in PTs is essential to understanding the underlying biological mechanisms and identifying new biomarkers and therapeutic strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used the GWAS dataset of PTs from the FinnGen database, a dataset of 486 plasma metabolites from the GWAS catalog database, and a dataset of 338 cerebrospinal fluid (CSF) metabolites from the WADRC and WRAP study collections. An inverse variance weighting (IVW) approach was utilized as the mainly method to investigate causality between metabolites and PTs, supplemented by four complementary methods to strengthen our findings. Additionally, we utilized several sensitivity methods to guarantee the robustness of our findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study identified 17 plasma metabolites and 10 CSF metabolites related to PTs. Among these, 11 metabolites indicated a significant positive causality with PTs, while 16 displayed a remarkable negative causality. Particularly, plasma levels of 3-dehydrocarnitine (OR = 2.73, 95% CI = 1.55\u20134.83, P = 0.001) and acetylcarnitine (OR = 0.35, 95% CI = 0.19\u20130.63, P = 0.001) were found to be significant exposure factors for PTs. Multiple sensitivity analyses confirm the robustness of the results. The study found no evidence of a reverse causality between PTs and the plasma levels of 3-dehydrocarnitine and acetylcarnitine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The present study identified 27 metabolites associated with the incidence of PTs, among which 3-dehydrocarnitine and acetylcarnitine are the most noteworthy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1460278","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:20:11Z","timestamp":1732767611000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Elucidating the causal links between plasma and cerebrospinal fluid metabolites and pituitary tumors: a Mendelian randomization analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Wencai","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0901-5","article-title":"Advances and controversies in the classification and grading of pituitary tumors","volume":"42","author":"Laws","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-019-00168-8","article-title":"Pituitary tumors: epidemiology and clinical presentation spectrum","volume":"19","author":"Araujo-Castro","year":"2020","journal-title":"Hormones (Athens)"},{"key":"B3","article-title":"Pituitary adenomas: an overview","volume":"88","author":"Lake","year":"2013","journal-title":"Am Fam Physician"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.5444","article-title":"Diagnosis and management of pituitary adenomas: A review","volume":"329","author":"Tritos","year":"2023","journal-title":"Jama"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00814","article-title":"Metabolomics-A promising approach to pituitary adenomas","volume":"9","author":"P\u00eenzariu","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0939-4","article-title":"Magnetic resonance\u00a0spectroscopy may serve as a presurgical predictor of somatostatin analog therapy response in patients with growth hormone-secreting pituitary macroadenomas","volume":"42","author":"Hu","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(96)00131-1","article-title":"Somatostatin stimulates BKCa channels in rat pituitary tumor cells through lipoxygenase metabolites of arachidonic acid","volume":"35","author":"Duerson","year":"1996","journal-title":"Neuropharmacology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.901884","article-title":"Metabolic characteristics and M2 macrophage infiltrates in invasive nonfunctioning pituitary adenomas","volume":"13","author":"Lin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c03796","article-title":"Strategy for identifying a robust metabolomic signature reveals the altered lipid metabolism in pituitary adenoma","volume":"96","author":"Tang","year":"2024","journal-title":"Anal Chem"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"Jama"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"Jama"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2982","article-title":"An atlas of genetic influences on human blood metabolites","volume":"46","author":"Shin","year":"2014","journal-title":"Nat Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s42003-020-01583-z","article-title":"Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations","volume":"4","author":"Panyard","year":"2021","journal-title":"Commun Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/nu15041057","article-title":"No evidence of a genetic\u00a0causal relationship between ankylosing spondylitis and gut microbiota: A two-sample mendelian randomization study","volume":"15","author":"Yang","year":"2023","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12967-023-04165-9","article-title":"Causality of genetically determined metabolites and metabolic pathways on osteoarthritis: a two-sample mendelian randomization study","volume":"21","author":"Gu","year":"2023","journal-title":"J Transl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000003090","article-title":"Impact of frailty on surgical outcomes of patients with cushing disease using the multicenter registry of adenomas of the pituitary and related disorders registry","author":"Findlay","year":"2024","journal-title":"Neurosurgery"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/10815589231169452","article-title":"Metabolomics in acromegaly: a systematic review","volume":"71","author":"P\u00eenzariu","year":"2023","journal-title":"J Investig Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2013-010821","article-title":"Identification of small compound biomarkers of pituitary adenoma: a bilateral inferior petrosal sinus sampling study","volume":"6","author":"Oklu","year":"2014","journal-title":"J neurointerv Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1038\/s41598-019-38542-6","article-title":"Ex Vivo (1)H NMR study of pituitary adenomas to differentiate various immunohistochemical subtypes","volume":"9","author":"Ijare","year":"2019","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2005.05.074","article-title":"Folate, vitamin E, and acetyl-L-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta","volume":"1061","author":"Dhitavat","year":"2005","journal-title":"Brain Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"Cd003158","DOI":"10.1002\/14651858.CD003158","article-title":"Acetyl-L-carnitine for dementia","volume":"2003","author":"Hudson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200212114038","article-title":"Potential therapeutic role of carnitine and acetylcarnitine in neurological disorders","volume":"26","author":"Maldonado","year":"2020","journal-title":"Curr Pharm Des"},{"key":"B25","first-page":"1","article-title":"Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion","volume":"21","author":"Calvani","year":"1999","journal-title":"Int J Tissue React"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(92)90170-N","article-title":"Actions of acetyl-L-carnitine on the hypothalamo-pituitary-gonadal system in female rats","volume":"43","author":"Krsmanovi\u0107","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2489","article-title":"Intact pituitary function is decisive for the catabolic response to TNF-\u03b1: studies of protein, glucose and fatty acid metabolism in hypopituitary and healthy subjects","volume":"100","author":"Bach","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.9b00637","article-title":"Untargeted lipidomics reveals specific lipid abnormalities in nonfunctioning human pituitary adenomas","volume":"19","author":"Hu","year":"2020","journal-title":"J Proteome Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1267\/ahc.21-00007","article-title":"Metabolic reprogramming drives pituitary tumor growth through epigenetic regulation of TERT","volume":"54","author":"Onizuka","year":"2021","journal-title":"Acta Histochem Cytochem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3390\/molecules23102583","article-title":"The various roles of fatty acids","volume":"23","author":"de Carvalho","year":"2018","journal-title":"Molecules"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br J Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02143-0","article-title":"Metabolic profiling of acromegaly using a GC-MS-based nontargeted metabolomic approach","volume":"67","author":"Yu","year":"2020","journal-title":"Endocrine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00678","article-title":"Integration of proteomics and metabolomics revealed metabolite-protein networks in ACTH-secreting pituitary adenoma","volume":"9","author":"Feng","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-14-0188","article-title":"The PI3K\/AKT\/mTOR pathway in the pathophysiology and treatment of pituitary adenomas","volume":"21","author":"Monsalves","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9682-3","article-title":"PI3K\/Akt\/mTOR and Raf\/MEK\/ERK signaling pathways perturbations in non-functioning pituitary adenomas","volume":"42","author":"Rubinfeld","year":"2012","journal-title":"Endocrine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.924942","article-title":"Architects of pituitary tumour growth","volume":"13","author":"Sabatino","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41598-020-58244-8","article-title":"Elevated levels of circulating betahydroxybutyrate in pituitary tumor patients may differentiate prolactinomas from other immunohistochemical subtypes","volume":"10","author":"Ijare","year":"2020","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0515","article-title":"Glutamine metabolism in the proliferation of GS-expression pituitary tumor cells","volume":"9","author":"Hu","year":"2020","journal-title":"Endocr Connect"},{"key":"B41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12964-023-01449-x","article-title":"Glutamine addiction in tumor cell: oncogene regulation and clinical treatment","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045061","article-title":"Multiple metabolic alterations exist in mutant PI3K cancers, but only glucose is essential as a nutrient source","volume":"7","author":"Foster","year":"2012","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.264","article-title":"mTOR promotes pituitary tumor development through activation of PTTG1","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.4.1252","article-title":"Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone","volume":"82","author":"Torres-Aleman","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1055\/a-2088-6594","article-title":"Transcriptome-derived ligand-receptor interactome of major pitNET subgroups","volume":"85","author":"Batchu","year":"2024","journal-title":"J Neurol Surg B Skull Base"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2174\/1389557043403305","article-title":"Cellular and physiological effects of arginine","volume":"4","author":"Tong","year":"2004","journal-title":"Mini Rev Med Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0697-7","article-title":"Autophagy maintains tumour growth through circulating arginine","volume":"563","author":"Poillet-Perez","year":"2018","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/137.6.1681S","article-title":"Arginine and immunity","volume":"137","author":"Popovic","year":"2007","journal-title":"J Nutr"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.09.031","article-title":"Analysis of cyclooxygenase 2, programmed cell death ligand 1, and arginase 1 expression in human pituitary adenoma","volume":"144","author":"Zhao","year":"2020","journal-title":"World Neurosurg"},{"key":"B50","doi-asserted-by":"publisher","first-page":"112686","DOI":"10.1016\/j.biopha.2022.112686","article-title":"Oxamate targeting aggressive cancers with special emphasis to brain tumors","volume":"147","author":"Altinoz","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.843887","article-title":"Biosynthetic pathway and metabolic engineering of succinic acid","volume":"10","author":"Liu","year":"2022","journal-title":"Front Bioeng Biotechnol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1460278\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:20:15Z","timestamp":1732767615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1460278\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":51,"alternative-id":["10.3389\/fendo.2024.1460278"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1460278","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"article-number":"1460278"}}